Catalyst Pharmaceuticals/ US14888U1016 /
| 7/1/2022 9:59:54 PM | Chg. +0.05 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 7.06USD | +0.64% | 60,062 Turnover: 421,432.01 |
-Bid Size: - | -Ask Size: - | 7.10 | 6.87 |
GlobeNewswire
3/16
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Bu...
GlobeNewswire
3/11
Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court ...
GlobeNewswire
3/3
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 16, ...
GlobeNewswire
2/24
Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on R...
GlobeNewswire
2/7
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2021 Total Revenues; Provi...
GlobeNewswire
2/3
Catalyst Pharmaceuticals Reports that the FDA Marketing Approval Previously Granted for Ruzurgi® is ...
GlobeNewswire
1/28
Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. Court of Appeals for the 11th Cir...
GlobeNewswire
1/10
Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Co...
GlobeNewswire
1/4
Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences
GlobeNewswire
12/6/2021
Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a Phase 3 Study for FIRDAPSE® (amifampr...
GlobeNewswire
11/15/2021
Catalyst Pharmaceuticals to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conferen...
GlobeNewswire
10/25/2021
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
GlobeNewswire
9/30/2021
Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exc...
GlobeNewswire
9/17/2021
Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech S...
GlobeNewswire
9/10/2021
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
GlobeNewswire
8/16/2021
Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
GlobeNewswire
8/9/2021
Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Upda...
GlobeNewswire
7/26/2021
Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial Results and Corporate Update Conferen...
GlobeNewswire
7/19/2021
Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Cl...